Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.61 |
| ▸ | MAOA | P21397 | 6/20 | 0.61 |
| ▸ | MAPT | P10636 | 6/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.61 |
| ▸ | DAPK1 | P53355 | 3/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | RECQL | P46063 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.61 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | TTR | P02766 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.61 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29883673 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAOAMAPTMAPK1 | |
| SCHEMBL11141991 | 0.89 | MEN1 (0.55) | MEN1KMT2AMAOAMAPTMAPK1 | |
| SCHEMBL11716746 | 0.88 | DAPK1 (0.58) | MEN1KMT2AMAOAMAPTMAPK1 | |
| SCHEMBL4835973 | 0.87 | MAPT (0.50) | MEN1KMT2AMAOAMAPTMAPK1 | |
| SCHEMBL899150 | 0.87 | MEN1 (0.68) | MEN1KMT2AMAOAMAPTMAPK1 | |
| Anthraquinone SCHEMBL10595870 | 0.85 | MEN1 (0.63) | MEN1KMT2AMAOAMAPTMAPK1 | |
| SCHEMBL10885940 | 0.84 | MAOA (0.55) | MEN1KMT2AMAOAMAPTMAPK1 | |
| SCHEMBL8581315 | 0.83 | MEN1 (0.63) | MEN1KMT2AMAOAMAPTMAPK1 | |
| SCHEMBL9296456 | 0.81 | MEN1 (0.56) | MEN1KMT2AMAOAMAPTMAPK1 | |
| SCHEMBL2908244 | 0.81 | MEN1 (0.47) | MEN1KMT2AMAOAMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115117467-A | Acid water system all-organic symmetrical battery based on dihydroxynaphthalene dione derivative | 常州大学 | 2022-09-27 | — | — | CN | claimed |
| US-9039946-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2015-05-26 | — | — | US | claimed |
| EP-1888705-B1 | Reversibly thermochromic compositions | BASF SE (DE) | 2010-08-18 | — | — | EP | claimed |
| US-20090302284-A1 | Reversibly Thermochromic Compositions | CIBA CORPORATION | 2009-12-10 | — | — | US | claimed |
| US-20090082574-A1 | Metallacycles and methods of making the same | ACADEMIA SINICA (TW) | 2009-03-26 | — | — | US | claimed |
| EP-1888705-A1 | REVERSIBLY THERMOCHROMIC COMPOSITIONS | Ciba Specialty Chemicals Holding, Inc. (CH) | 2008-02-20 | — | — | EP | claimed |
| WO-2006131465-A1 | REVERSIBLY THERMOCHROMIC COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-12-14 | — | — | WO | claimed |
| WO-2026078075-A1 | METAL COORDINATION COMPLEXES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2026-04-16 | — | — | WO | disclosed |
| CN-115117467-A | Acid water system all-organic symmetrical battery based on dihydroxynaphthalene dione derivative | 常州大学 | 2022-09-27 | — | — | CN | disclosed |
| EP-2888116-B1 | SECURITY AND/OR VALUE DOCUMENT CONTAINING A VISUAL SWITCHABLE WINDOW WITH A HOLOGRAM | COVESTRO DEUTSCHLAND AG (DE) | 2016-09-21 | — | — | EP | disclosed |
| US-9039946-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2015-05-26 | — | — | US | disclosed |
| US-9039946-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2015-05-26 | — | — | US | disclosed |
| CN-101189318-B | Reversibly thermochromic compositions | CIBA SC HOLDING AG | 2012-06-20 | — | — | CN | disclosed |
| WO-2006131465-A1 | REVERSIBLY THERMOCHROMIC COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-12-14 | — | — | WO | disclosed |
| WO-2006131465-A1 | REVERSIBLY THERMOCHROMIC COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-12-14 | — | — | WO | disclosed |
| WO-2006121522-A2 | IMPLANTABLE SENSORS AND PUMPS, ANTI-SCARRING AGENTS, AND THERAPEUTIC COMPOSITIONS | ANGIOTECH INTERNATIONAL AG (CH) | 2006-11-16 | — | — | WO | disclosed |
| WO-2006121518-A2 | ELECTRICAL DEVICES, ANTI-SCARRING AGENTS, AND THERAPEUTIC COMPOSITIONS | ANGIOTECH INTERNATIONAL AG (CH) | 2006-11-16 | — | — | WO | disclosed |
| US-20060207891-A1 | System and method for electrochemical detection of biological compounds | HANDYLAB, INC. (US) | 2006-09-21 | — | — | US | disclosed |
| WO-2004094986-A2 | SYSTEM AND METHOD FOR ELECTROCHEMICAL DETECTION OF BIOLOGICAL COMPOUNDS | HANDYLAB, INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| US-4739062-A | REACTING AN AROMATIC COMPOUND WITH DICARBOXYLIC ACID COMPOUND USING METAL HALIDE CATALYST | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1988-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090302284-A1 | Reversibly Thermochromic Compositions | DHCR7, NES, DUT | MEN1 946/4885KMT2A 1932/4885MAOA 3289/4885 |
| US-20090082574-A1 | Metallacycles and methods of making the same | SOD1, PMS2, MEN1 | MEN1 3/4885KMT2A 686/4885MAOA 1121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.